Browsing Tag

PRNewswire

43332 posts
Huawei Hosts 3rd Global C&I Visionaries Summit, Shaping a Greener Future Across Diverse Industries

Huawei Hosts 3rd Global C&I Visionaries Summit, Shaping a Greener Future Across Diverse Industries

DONGGUAN, China, May 26, 2026 /PRNewswire/ — Huawei Digital Power hosted the…
TCL Zhonghuan Launches Next-Generation BC Module at Tianjin Manufacturing Base

TCL Zhonghuan Launches Next-Generation BC Module at Tianjin Manufacturing Base

TIANJIN, China, May 26, 2026 /PRNewswire/ — TCL Zhonghuan ("TCL Zhonghuan Renewable Energy…
HTX Launches " Margin Trade": Start Trading with Just 1 USDT, Enjoy Guaranteed First-Loss Coverage, Plus Share ,000 in Rewards

HTX Launches "$1 Margin Trade": Start Trading with Just 1 USDT, Enjoy Guaranteed First-Loss Coverage, Plus Share $40,000 in Rewards

PANAMA CITY, May 26, 2026 /PRNewswire/ — For crypto beginners, the steep learning…
SC Unveils Thailand's Most Prestigious Ultra-Luxury Residences for the Global Elite

SC Unveils Thailand's Most Prestigious Ultra-Luxury Residences for the Global Elite

BANGKOK, May 25, 2026 /PRNewswire/ — Under the vision of SC Master…
YUEWEN seeks global partners for 'Lord of Mysteries' after record fan activation

YUEWEN seeks global partners for 'Lord of Mysteries' after record fan activation

Chinese web fiction IP draws brands across 34 countries as YUEWEN opens…
AHA Connection Day: Socialite Hospitality Night brings together Australia-Vietnam's Hospitality and Tourism community in Nha Trang

AHA Connection Day: Socialite Hospitality Night brings together Australia-Vietnam's Hospitality and Tourism community in Nha Trang

Nha Trang, Vietnam, May 25, 2026 /PRNewswire/ — Hosted by the Australian Hospitality…

Cyient Semiconductors Announces Strategic Financing with Edelweiss at ~ USD 500 Mn. Equity Valuation

HYDERABAD, India, May 25, 2026 /PRNewswire/ — Cyient Semiconductors today announced a…

Pierre Fabre Laboratories receives CHMP positive opinion for BRAFTOVI® (encorafenib) in combination with cetuximab and FOLFOX (fluorouracil, leucovorin, and oxaliplatin) for the first-line treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer (mCRC)

This positive CHMP opinion is based on results from the Phase 3…